68 related articles for article (PubMed ID: 11407912)
1. Development of a competitive PCR method for physical titration of recombinant EBV vector in a helper-dependent packaging system.
Wang J; Vos JM
Mol Ther; 2001 Jun; 3(6):976-83. PubMed ID: 11407912
[TBL] [Abstract][Full Text] [Related]
2. Genetic design of an optimized packaging cell line for gene vectors transducing human B cells.
Hettich E; Janz A; Zeidler R; Pich D; Hellebrand E; Weissflog B; Moosmann A; Hammerschmidt W
Gene Ther; 2006 May; 13(10):844-56. PubMed ID: 16421600
[TBL] [Abstract][Full Text] [Related]
3. Development of a size-restricted pIX-deleted helper virus for amplification of helper-dependent adenovirus vectors.
Sargent KL; Ng P; Evelegh C; Graham FL; Parks RJ
Gene Ther; 2004 Mar; 11(6):504-11. PubMed ID: 14999222
[TBL] [Abstract][Full Text] [Related]
4. Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus.
Delecluse HJ; Feederle R; Behrends U; Mautner J
Semin Cancer Biol; 2008 Dec; 18(6):409-15. PubMed ID: 18938248
[TBL] [Abstract][Full Text] [Related]
5. High level of transgene expression in primary chronic lymphocytic leukemia cells using helper-virus-free recombinant Epstein-Barr virus vectors.
Wendtner CM; Kurzeder C; Theiss HD; Kofler DM; Baumert J; Delecluse HJ; Janz A; Hammerschmidt W; Hallek M
Exp Hematol; 2003 Feb; 31(2):99-108. PubMed ID: 12591274
[TBL] [Abstract][Full Text] [Related]
6. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
7. Infectious delivery of 120-kilobase genomic DNA by an epstein-barr virus amplicon vector.
White RE; Wade-Martins R; James MR
Mol Ther; 2002 Apr; 5(4):427-35. PubMed ID: 11945070
[TBL] [Abstract][Full Text] [Related]
8. Engineering a mini-herpesvirus as a general strategy to transduce up to 180 kb of functional self-replicating human mini-chromosomes.
Sun TQ; Livanos E; Vos JM
Gene Ther; 1996 Dec; 3(12):1081-8. PubMed ID: 8986434
[TBL] [Abstract][Full Text] [Related]
9. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
[TBL] [Abstract][Full Text] [Related]
10. Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods.
Sastry L; Johnson T; Hobson MJ; Smucker B; Cornetta K
Gene Ther; 2002 Sep; 9(17):1155-62. PubMed ID: 12170379
[TBL] [Abstract][Full Text] [Related]
11. Replication and packaging of helper-dependent adenoviral vectors.
Sato M; Suzuki S; Kubo S; Mitani K
Gene Ther; 2002 Apr; 9(7):472-6. PubMed ID: 11938462
[TBL] [Abstract][Full Text] [Related]
12. Efficient delivery and stable gene expression in a hematopoietic cell line using a chimeric serotype 35 fiber pseudotyped helper-dependent adenoviral vector.
Balamotis MA; Huang K; Mitani K
Virology; 2004 Jun; 324(1):229-37. PubMed ID: 15183069
[TBL] [Abstract][Full Text] [Related]
13. Gutted adenoviral vector growth using E1/E2b/E3-deleted helper viruses.
Barjot C; Hartigan-O'Connor D; Salvatori G; Scott JM; Chamberlain JS
J Gene Med; 2002; 4(5):480-9. PubMed ID: 12221641
[TBL] [Abstract][Full Text] [Related]
14. Development of a novel helper-dependent adenovirus-Epstein-Barr virus hybrid system for the stable transformation of mammalian cells.
Dorigo O; Gil JS; Gallaher SD; Tan BT; Castro MG; Lowenstein PR; Calos MP; Berk AJ
J Virol; 2004 Jun; 78(12):6556-66. PubMed ID: 15163748
[TBL] [Abstract][Full Text] [Related]
15. Production of an infectious Herpesvirus saimiri-based episomally maintained amplicon system.
Macnab S; White R; Hiscox J; Whitehouse A
J Biotechnol; 2008 Apr; 134(3-4):287-96. PubMed ID: 18328588
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of a quantitative real time polymerase chain reaction assay for diagnosis of primary Epstein-Barr virus infection in children.
Pitetti RD; Laus S; Wadowsky RM
Pediatr Infect Dis J; 2003 Aug; 22(8):736-9. PubMed ID: 12913777
[TBL] [Abstract][Full Text] [Related]
17. Quantitation of encapsidated recombinant adeno-associated virus DNA in crude cell lysates and tissue culture medium by quantitative, real-time PCR.
Mayginnes JP; Reed SE; Berg HG; Staley EM; Pintel DJ; Tullis GE
J Virol Methods; 2006 Nov; 137(2):193-204. PubMed ID: 16860883
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Epstein-Barr virus replication by small interfering RNA targeting the Epstein-Barr virus protease gene.
Larrat S; Morand P; Bas A; Vigne S; Crance JM; Boyer V; Nicod S; Grossi L; Buisson M; Burmeister WP; Seigneurin JM; Germi R
Antivir Ther; 2009; 14(5):655-62. PubMed ID: 19704168
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus vector-mediated gene transfer into human B cells: potential for antitumor vaccination.
Hellebrand E; Mautner J; Reisbach G; Nimmerjahn F; Hallek M; Mocikat R; Hammerschmidt W
Gene Ther; 2006 Jan; 13(2):150-62. PubMed ID: 16136164
[TBL] [Abstract][Full Text] [Related]
20. Production of helper-dependent adenovirus vector relies on helper virus structure and complementing.
Zhou HS; Zhao T; Rao XM; Beaudet AL
J Gene Med; 2002; 4(5):498-509. PubMed ID: 12221643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
